Skip to Main Content

Paper Details

HIV clinic-based extended-release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non-blinded, randomized non-inferiority trial.
Addiction
8
2022
HIV, HIV RNA, NTX, OUD, Participants, TAU, XR, buprenorphine, cocaine, fentanyl, human, human immunodeficiency virus, methadone, naltrexone, opioid use disorder, participants, people
Author NameAffiliation
Philip Todd KorthuisOregon Health and Science University
Philip Todd KorthuisOregon Health and Science University-Portland State University School of Public Health
Elizabeth Needham WaddellOregon Health and Science University
Elizabeth Needham WaddellOregon Health and Science University-Portland State University School of Public Health
  • 1 - 4

Datasets

Release 1.2